FDA Warning Letter — FairyGene, Inc.
The FDA took a Warning Letter action against FairyGene, Inc. on July 31, 2026 (Bristol, PA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- FairyGene, Inc.
- Date
- July 31, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Bristol, PA (United States)